ClinicalTrials.gg
Not yet recruitingNCT07929324Updated Nov 10, 2026

Breaking the Cycle of Pain With Clinical Pilates

An observational study in Musculoskeletal Disorder, sponsored by Nanyang Technological University. Not yet recruiting at 1 site in Singapore. Open to participants aged 21 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Nanyang Technological University · Observational

Updated Nov 10, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
60
Ages
21 Years to 70 Years
Sex
All
01

Study summary

The objective of this pilot study is to examine the feasibility of implementing Dance Medicine Australia (DMA) Clinical Pilates treatments for a diverse group of adult patients with various musculoskeletal problems, such as low back pain, knee pain and shoulder pain, at a local rehabilitation clinic. To ensure accessibility and generalisability within a community context, the project will collaborate with The Rehab Circle, a local rehabilitation clinic where DMA-certified physiotherapists will provide interventions. After a clinical examination, patients will receive supervised DMA Clinical Pilates mat and/or equipment exercise interventions tailored to their individual movement preferences.

02

Conditions studied

  • Musculoskeletal Disorder

Keywords

  • Physiotherapy
  • Rehabilitation
03

In context

Musculoskeletal Diseases

752 studies on the registry are indexed under Musculoskeletal Diseases; 164 are open to participants now.

This study's planned enrollment of 60 is below the median of 120 across 207 observational studies indexed under Musculoskeletal Diseases.

Browse Musculoskeletal Diseases studies →

Lead sponsor

Nanyang Technological University is the lead sponsor of 52 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Individuals with musculoskeletal conditions in Singapore

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients with musculoskeletal problems aged 21 to 70 years who are deemed suitable for DMA Clinical Pilates will be invited to participate in this project.
  • Diagnostic characteristics include the presence of multiple body regions with musculoskeletal problems, medical diagnosis, whether the patient is scheduled for surgery, duration of symptoms and co-morbidities such as diabetes and hypertension.

Exclusion criteria

Exclusion Criteria:

- Patients with symptoms of cancer or ongoing cancer management, spinal fractures (past 3 months), cauda equina lesion, complete loss of bladder/bowel control or saddle paraesthesia, known pregnancy, or spinal inflammatory disease such as ankylosing spondylitis and rheumatoid arthritis will be excluded.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
60 participants (estimated)
Patient registry
No

Groups and cohorts

  • Clinical Pilates Group

    After a clinical examination, patients will receive supervised DMA Clinical Pilates mat and/or equipment exercise interventions tailored to their individual movement preferences. Physiotherapists will determine the intensity, frequency, and progression of exercise, considering patients' physical conditions.

    Other: Clinical Pilates

Interventions

  • OtherClinical Pilates

    Clinical Pilates is easy to do and pain-free, catering to individual patients' needs. The working principle of DMA Clinical Pilates stems from neuromuscular training, involving simple exercises in the early stage of rehabilitation to prevent compensatory muscle activity. This approach allows for motor relearning through the corticospinal tract and minimises stress on the spinal structures, leading to decreased pain and improved movement control.

06

What researchers measure

Primary outcomes

  1. Numeric Pain Rating Scale

    Patients will report the level of pain associated with musculoskeletal disorders on a scale from 0 to 10. 0 indicates no pain, while 10 indicates severe pain.

    Time frame: Baseline, through completion of supervised Clinical Pilates treatment (an average of 6 weeks), 6-month and 12-month follow-ups.

Secondary outcomes

  1. Patient-Specific Functional Scale

    Patients identify 3 to 5 everyday activities they struggle with due to injury and score them on an 11-point scale from 0 (unable to perform) to 10 (able to perform at their prior level).

    Time frame: Baseline, through completion of supervised Clinical Pilates treatment (an average of 6 weeks), 6-month and 12-month follow-ups.

  2. Oswestry Disability Index

    The Oswestry Disability Index (ODI) is a questionnaire used by clinicians to measure the extent to which low back pain affects a patient's daily functional activities. It assesses 10 categories, including pain intensity, lifting, walking, sleeping, and social life. The questionnaire consists of 10 sections, each scored from 0 to 5 points (maximum possible score of 50). This questionnaire is applicable only to patients with back conditions.

    Time frame: Baseline, through completion of supervised Clinical Pilates treatment (an average of 6 weeks), 6-month and 12-month follow-ups.

  3. Neck Disability Index

    The Neck Disability Index (NDI) is the standard 10-item questionnaire used to assess how neck pain affects patients' daily life. Each of the 10 sections is scored on a 6-point scale from 0 (no disability) to 5 (worst possible limitation). It evaluates areas such as personal care, lifting, reading, headaches, work, and sleep. Each of the 10 sections is scored on a 6-point scale from 0 (no disability) to 5 (worst possible limitation). This questionnaire is applicable only to patients with neck conditions.

    Time frame: Baseline, through completion of supervised Clinical Pilates treatment (an average of 6 weeks), 6-month and 12-month follow-ups.

  4. Upper Extremity Functional Index

    The Upper Extremity Functional Index (UEFI) is a 20-item patient-reported questionnaire that measures how upper-limb conditions (shoulder, wrist, or hand injuries) affect daily activities. Patients rate 20 specific activities on a 0-4 Likert scale. The total score ranges from 0 to 80. Higher scores (closer to 80) indicate better, unrestricted upper-limb function. Lower scores (closer to 0) indicate greater functional limitation or disability. This questionnaire is applicable only to patients with upper-limb conditions.

    Time frame: Baseline, through completion of supervised Clinical Pilates treatment (an average of 6 weeks), 6-month and 12-month follow-ups.

  5. Lower Extremity Functional Index

    The Lower Extremity Functional Scale (LEFS) is a 20-item patient-reported questionnaire measuring how lower-limb problems affect daily activities. Patients rate 20 everyday physical activities on a 5-point scale (0 to 4) according to the difficulty they experience today due to their leg problem. Total scores range from 0 (extreme disability) to 80 (high function). Lower scores indicate greater functional impairment and disability, while higher scores indicate higher function and less disability. This questionnaire is applicable only to patients with lower-limb conditions.

    Time frame: Baseline, through completion of supervised Clinical Pilates treatment (an average of 6 weeks), 6-month and 12-month follow-ups.

  6. Short Form 12

    The Short Form 12 (SF-12) is a 12-item, patient-reported health questionnaire measuring an individual's overall health-related quality of life. It assesses eight health domains, including physical functioning, bodily pain, vitality, and mental health, and generates two standardised composite scores: the Physical Component Summary (PCS) and the Mental Component Summary (MCS).

    Time frame: Baseline, through completion of supervised Clinical Pilates treatment (an average of 6 weeks), 6-month and 12-month follow-ups.

  7. Adverse events

    The number of adverse events will be documented.

    Time frame: Baseline, through completion of supervised Clinical Pilates treatment (an average of 6 weeks), 6-month and 12-month follow-ups.

  8. Number of pain recurrences

    The number of pain recurrences will be documented.

    Time frame: Baseline, through completion of supervised Clinical Pilates treatment (an average of 6 weeks), 6-month and 12-month follow-ups.

07

Study locations

1 site
  • The Rehab Circle
    Singapore, S640952, Singapore
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will be shared upon reasonable requests.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2026; primary completion for Dec 2029, 36 months later.

Of 86 non-industry observational studies under Musculoskeletal Diseases, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 60. This study's planned 36 months is above that.

Counting every sponsor, half of 107 studies reached it within 27 months; a quarter within 7 and three quarters within 72.

Musculoskeletal Diseases covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 1, 2026
First posted
Nov 10, 2026
StartEst.
Dec 1, 2026
Primary completionEst.
Dec 1, 2029
CompletionEst.
Dec 1, 2029
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07929324
Lead sponsor
Nanyang Technological University
Responsible party
Kong Pui Wah (Associate Professor, Nanyang Technological University) — Principal investigator
First posted
Nov 10, 2026
Start date
Dec 1, 2026 (estimated)
Primary completion
Dec 1, 2029 (estimated)
Completion
Dec 1, 2029 (estimated)
Last update
Nov 10, 2026

Study contacts

Pui Wah KONG, PhD
Contact
puiwah.kong@nie.edu.sg
(65) 67903897
Pui Wah Kong, PhD
principal investigator · Physical and Sports Science Department, National Institute of Education, Nanyang Technological University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion